血管-POPS:慢性肢体威胁性缺血管理新标准的证据
POPS整合老年综合评估(CGA),住院时间依次缩短(17天 vs 13天 vs 11天,P<.001),30天急性肾损伤、心肌梗死和医院获得性肺炎减少,12个月死亡率分别降低37%和40%。
要点
- POPS整合CGA使非择期CLTI患者住院时间从17天依次降至13天和11天。
- 30天急性肾损伤、心肌梗死和医院获得性肺炎在POPS期显著减少。
- POPS v1和v2的12个月死亡率分别降低37%和40%,经济分析示财务可持续。
核心结论
- 血管-POPS协作服务显著改善非择期CLTI患者的住院时间、不良事件和生存率,且财务可持续。
主要发现
- 住院时间随POPS投入增加依次缩短:17天 vs 13天 vs 11天(P<.001)。
- 30天急性肾损伤发生率33% vs 37% vs 8%(P<.001),心肌梗死15% vs 2% vs 2%(P<.001),医院获得性肺炎17% vs 10% vs 9%(P=.048)。
- Cox生存回归显示12个月死亡率POPS v1降低37%[HR 0.628(95%CI 0.481-0.891)P=.013],POPS v2降低40%[HR 0.598(95%CI 0.431-0.913)P=.001]。
- 经济分析发现处理更多医学复杂患者且住院时间更短可抵消其运营成本。
临床怎么用
- 对非择期CLTI住院患者应整合CGA的POPS服务,以缩短住院时间、减少不良事件并改善生存。
局限性
- 单中心前瞻性观察性设计,非随机对照,结论可能受中心实践和未测混杂因素影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Patients with chronic limb-threatening ischaemia (CLTI) are often admitted emergently with significant comorbidity and frailty, and little time for pre-optimisation, resulting in longer hospital stays and worse outcomes. Our unit implemented a POPS (Perioperative Medicine for the Older Person undergoing Surgery) service, incorporating the comprehensive geriatric assessment (CGA) to optimise patients. This study assesses its effect on non-elective CLTI inpatients. METHODS: This is a prospective observational cohort study at a single vascular centre, analysing outcomes in non-elective CLTI patients over three different periods: one year prior to POPS ('Pre-POPS'); during the initial delivery when it was nurse-led ('POPS v1'); and after it became physician-led ('POPS v2'). The primary outcome was length of stay (LoS), with 30-day and 12-month secondary outcomes. Cohorts were compared using propensity-score weighted statistical analysis. Economic analysis was undertaken. RESULTS: Six hundred and two patients were included. LoS reduced sequentially with greater POPS input (17 days vs. 13 days vs. 11 days, P < .001). There was a significant reduction in 30-day acute kidney injury (33% vs. 37% vs. 8%, P < .001), myocardial infarction (15% vs. 2% vs. 2% P < .001) and hospital-acquired pneumonia (17% vs. 10% vs. 9%, P = .048). Cox survival regression found a reduction in 12-month mortality of 37% for the POPS v1 [HR 0.628 (95% CI 0.481-0.891) P = .013] and 40% for the POPS v2 [HR 0.598 (95% CI 0.431-0.913) P = .001] cohorts, respectively. Economic analysis found that handling more medically complex patients with a shorter LoS negated its operational costs. CONCLUSION: A Vascular-POPS collaborative service has resulted in major improvements in LoS, adverse events and survival in this most vulnerable of vascular patient cohorts and is a financially sustainable initiative.
引用
- Khan A, Davies H, Fawcett LE, et al. Vascular-POPS: evidence for a new standard of care in the management of chronic limb-threatening Ischaemia. Age Ageing. 2026. PMID: 41609321. doi:10.1093/ageing/afag003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。